Published on 25 Mar 2024 on Insider Monkey via Yahoo Finance
What Makes Fresenius Medical Care AG (FMS) a Potential Investment?
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the Ariel Global fund returned +8.40% gross of fees (+8.18% net of fees), compared to the MSCI ACWI Index’s +11.03%, and the MSCI ACWI Value Index’s +9.17% gains. The fund appreciated +13.96% gross of fees (+13.06% net of fees) over the trailing year, underperforming the MSCI ACWI Index’s +22.20% return and ahead of the MSCI ACWI Value Index’s +11.81% return. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.
Ariel Global Fund featured stocks like Fresenius Medical Care AG (NYSE:FMS) in the fourth quarter 2023 investor letter. Headquartered in Bad Homburg, Germany, Fresenius Medical Care AG (NYSE:FMS) provides dialysis and related services. On March 22, 2024, Fresenius Medical Care AG (NYSE:FMS) stock closed at $18.74 per share. One-month return of Fresenius Medical Care AG (NYSE:FMS) was -3.43%, and its shares lost 8.45% of their value over the last 52 weeks. Fresenius Medical Care AG (NYSE:FMS) has a market capitalization of $11.404 billion.
Ariel Global Fund stated the following regarding Fresenius Medical Care AG (NYSE:FMS) in its fourth quarter 2023 investor letter: